Lunsumio Velo Injection
Product Images NDC 50242-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lunsumio Velo (NDC 50242-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lunsumio 01)

This text provides information on the concentration of Mosunetuzumab-axgb over time, showing the median and 90th percentile prediction interval values. The concentration values range from 0.001 to 168 at different time points (Day).*

FDA Label Image

Principal Display Panel (5 mg/0.5 mL Vial Carton)

This text contains information about a medication called Lunsumio Velo (mosunetuzumab-axgb) in injection form for subcutaneous use. The NDC code is 50242-177-01, and it is a single-dose vial that should be discarded if unused. It is important to dispense the enclosed Medication Guide to each patient.*

FDA Label Image

Principal Display Panel (45 mg/mL Vial Carton)

This is a product information for Lunsumio Velo™, specifically for the medication called mosunetuzumab-axgb in injection form for subcutaneous use only. The single-dose vial must be discarded if any portion is unused. It is recommended to dispense the enclosed Medication Guide to each patient. The manufacturer is Genentech.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.